Core Insights - UnitedHealth Group Incorporated (UNH) and Centene Corporation (CNC) are key players in the healthcare industry, benefiting from increasing healthcare demand, an aging population, and a rise in chronic diseases [1] - UnitedHealth is in a strong leadership position with steady execution, while Centene is undergoing a turnaround focused on efficiency and margin recovery [2] UnitedHealth Overview - UnitedHealth has a market cap of $250.1 billion and operates with a dual-engine model, combining insurance through UnitedHealthcare and technology-enabled health services via Optum [4] - The company reported a 12% revenue growth in its latest quarter, driven by growth in commercial fee-based membership and Optum Rx [5] - Despite the revenue growth, adjusted earnings fell by 69% year over year due to high medical costs and a decline in risk-based membership [5] - UnitedHealth's profitability is supported by its scale, data integration, and care delivery capabilities, with estimated operating cash flows of $18 billion in 2026 [6] - The company plans to repurchase $2.5 billion in shares and pay $8 billion in dividends [6] Centene Overview - Centene has a market cap of $16.9 billion and focuses heavily on government-sponsored programs, particularly Medicaid, which exposes it to policy changes [8] - In its most recent quarter, Centene's revenues increased by 21.9% year over year, but it reported a loss of $1.19 per share compared to earnings of 80 cents per share a year ago [9] - The company is working on margin recovery by exiting underperforming markets and repricing contracts, but faces structural challenges [9] - Centene's return on invested capital is 3.76%, lower than UnitedHealth's 5.37% [9] Financial Comparisons - UnitedHealth's margins and cash flow are stronger compared to Centene, which has higher risk and is in a turnaround phase [10] - Centene's medical loss ratio (HBR) is projected to be between 90.9% and 91.7% for 2026, while UnitedHealth expects a medical cost ratio (MCR) of 88.8% [11] - Centene's long-term debt-to-capital ratio is 46.45%, higher than UnitedHealth's 42.48%, indicating greater financial leverage [12] Earnings Estimates - For UnitedHealth, the Zacks Consensus Estimate forecasts 2026 EPS of $17.70, reflecting an 8.3% year-over-year growth [13] - Centene's 2026 earnings estimate stands at $3.05 per share, implying a 46.6% year-over-year growth as cost pressures ease [14] Valuation and Price Performance - UnitedHealth trades at a forward P/E of 15.17X, while Centene trades at 10.51X, reflecting UnitedHealth's superior earnings visibility and lower risk [15] - Over the past month, UnitedHealth's shares gained 0.6%, outperforming Centene and the broader market [17] - UnitedHealth's average price target suggests a 28.1% upside, while Centene's indicates a 23.7% upside [20] Conclusion - Both companies are positioned to benefit from long-term healthcare trends, but UnitedHealth offers greater stability and a more consistent growth trajectory compared to Centene's uncertain outlook [21][22]

Core Insights - UnitedHealth Group's health benefits segment, UnitedHealthcare, is facing profitability pressures despite a revenue increase of 15.7% in 2025 to $344.9 billion, with adjusted operating earnings dropping 41.1% to $9.6 billion due to reduced Medicare funding and high medical costs [1][9] Revenue and Earnings - The adjusted operating margin decreased significantly to 2.8% from 5.4% year-over-year, while the medical care ratio increased to 89.1% from 85.5%, indicating higher patient care spending [2] - For 2026, management anticipates operating earnings to exceed $10.8 billion, with the medical care ratio projected between 88.3% and 89.3% due to repricing actions [2] Membership and Enrollment - UnitedHealthcare served 49.8 million individuals in 2025, a modest increase of 0.8% year-over-year, but Commercial Risk Based enrollment saw a decline of 7.7% [3] - Total medical membership is expected to range between 46.945 million and 47.495 million in 2026, reflecting declines across various plans [3] Revenue Guidance - The revenue outlook for 2026 is projected to be over $439 billion, which is a decrease from $447.6 billion in 2025, marking the first annual revenue contraction in decades [4] Medicare Advantage Concerns - A proposed 0.09% increase in 2027 Medicare Advantage payment rates is below expectations, which is critical as Medicare Advantage accounts for nearly half of UnitedHealthcare's revenues [5] Industry Context - Peers such as Centene Corporation and Elevance Health are also experiencing pressure from rising medical costs, with Centene's health benefits ratio increasing to 91.9% and Elevance's benefit expense ratio rising to 90% in 2025 [6][7] Stock Performance and Valuation - UnitedHealth's shares have declined by 19.7% over the past month, compared to a 14.9% decline in the industry [8] - The company trades at a forward price-to-earnings ratio of 15.67, above the industry average of 14.09, and holds a Value Score of A [11]